Pharmaceutical

WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe

Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers of their diabetes and weight loss drugs.

Jun 22, 2024 - 04:00
WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe
Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers of their diabetes and weight loss drugs.
Read the original article

Tags:

Previous Article

Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio

Next Article

South Korea seeks to accelerate drug reimbursement administration process

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How social responsibility M&A performed in the pharmace...

Jul 27, 2023

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

Market cap rebound by top 20 biopharmaceutical companie...

Sep 15, 2023

FDA warns some Philips respirators may not deliver the right treatment

FDA warns some Philips respirators may not deliver the ...

Apr 9, 2023